Contact Us

Bringing a medical device to market requires navigating strict FDA regulations. Success depends on understanding which devices need approval, selecting the right regulatory pathway, and planning for every phase of development.

Which Devices Require FDA Approval?

The FDA classifies devices by risk:

  • Class I (low risk): Often only require self-registration (e.g., bandages).

  • Class II (moderate risk): Typically need 510(k) clearance by proving substantial equivalence (e.g., infusion pumps).

  • Class III (high risk): Require PMA approval with strong clinical evidence (e.g., pacemakers).

Product Development Phases

Approval involves more than ideation and design—it requires a complete lifecycle approach: research, prototyping, verification/validation, clinical studies (if needed), regulatory submission, FDA review, and post-market monitoring.

Main FDA Regulatory Pathways

  • Self-Registration (Class I) – Establishment registration and listing.

  • 510(k) Submission (Class II) – Clearance based on equivalence to a predicate.

  • De Novo – For novel, low/moderate-risk devices with no predicate.

  • PMA (Class III) – Full approval with extensive clinical data.

👉 Clearance vs. Approval:

  • Clearance (510(k)) = substantial equivalence.

  • Approval (PMA) = direct proof of safety and effectiveness.

Interacting with the FDA

The old Pre-IDE process is now the Q-Submission (Q-Sub) program. Companies can request feedback or a Pre-Sub meeting to align expectations before formal submission.

FDA Review and Market Entry

The FDA evaluates safety, efficacy, labeling, and quality systems. Once cleared or approved, commercialization can proceed under strict post-market compliance.

Conclusion

FDA approval or clearance requires more than a prototype—it demands strategy, evidence, and regulatory alignment. By identifying the correct pathway and engaging early with the FDA, companies can bring safe, effective devices to patients faster.

Contact Us

Contact Us

Contact us

Testimonials

“Bioana team, you guys are simply amazing. Thanks so much for all your team’s hard work on this. We remain impressed beyond measure.”

Mark Lee

CEO, Ocumetics

"Our experience with Bioana had been outstanding. Their commitment, eye for detail, punctuality, proactivity and understanding manufacturing principles, workflow, quality and resourcefulness has been beyond our expectations."

Frank Harder

CRO , Bolb Inc.

Schedule a call today

Got any questions?

Schedule a Call